• Online Features  This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Joan Orlando, MD; Wilbert S. Aronow, MD

Arch Intern Med. 1979;139(11):1298-1301.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The hemodynamic consequences of supraventricular tachyarrhythmias may be trivial or serious depending on the presence and severity or absence of underlying heart disease and on the duration of the tachyarrhythmia. It is important to recognize and emphasize that the treatment of supraventricular tachyarrhythmias must be tailored to the individual setting in which it occurs, and that full understanding of the clinical circumstances in which these tachyarrhythmias develop is essential for optimal therapy in individual patients. Treatment of these tachyarrhythmias includes treatment of the underlying disease. Precipitating factors, such as use of alcohol, tobacco, and coffee, also should be eliminated when feasible.

We wish to emphasize that there is no "cookbook" approach to the management of supraventricular tachyarrhythmias. Moreover, no one should use any antiarrhythmic drug without understanding its pharmacologic and physiologic mechanisms.

PAROXYSMAL ATRIAL TACHYCARDIA AND PAROXYSMAL ATRIOVENTRICULAR JUNCTIONAL TACHYCARDIA

The ventricular rate in paroxysmal atrial tachycardia (PAT) and in . . . [Full Text PDF of this Article]

Author Affiliations

Footnotes

Reprint requests to Cardiovascular Section, Veterans Administration Medical Center, Long Beach, CA 90822 (Dr Aronow).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?